Title : Preclinical efficacy of the MDM 2 inhibitor RG 7112 in MDM 2 amplified and TP 53 wild - type glioblastomas
نویسندگان
چکیده
Title: Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2 amplified and TP53 wild-type glioblastomas Authors: Maite Verreault, Charlotte Schmitt, Lauriane Goldwirt, Kristine Pelton, Samer Haidar, Camille Levasseur, Jeremy Guehennec, David Knoff, Marianne Labussiere, Yannick Marie, Azra H. Ligon, Karima Mokhtari, Khe Hoang-Xuan, Marc Sanson, Brian M Alexander, Patrick Y. Wen, Jean-Yves Delattre, Keith L. Ligon, Ahmed Idbaih Affiliations: 1: Inserm, U 1127, F-75013, Paris, France ; 2: CNRS, UMR 7225, F75013, Paris, France ; 3: Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, F-75013, Paris, France ; 4: Institut du Cerveau et de la Moëlle épinière, ICM, 47, Bd de l’Hôpital, F-75013, Paris, France ; 5: AP-HP, Hôpital universitaire Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, 47, Bd de l’Hopital, F-75013, Paris, France; 6: APHP, Hôpital de la Pitié-Salpêtrière, Service de Neuropathologie R Escourolle, 47, Bd de l’Hopital, F-75013, Paris, France; 7: OncoNeuroThèque biobank, Institut du Cerveau et de la Moëlle épinière, ICM, 47, Bd de l’Hopital, F-75013, Paris, France; 8: Department of Medical Oncology, Center for Molecular Oncologic Pathology, DanaFarber Cancer Institute, 450 Brookline Ave, MA, Boston, Massachusetts, USA, 02115; 9: Department of Pathology, Brigham and Women's Hospital, 75, Francis Street, Boston, MA, USA, 02115; 10: Department of Pathology, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA, 02115; 11: Institut du Cerveau et de la Moëlle épinière, Centre de neuroimagerie de recherche, CHU Pitié-Salpêtrière, 47, Bd de l’Hopital, 75013, Paris, France; 12: Laboratoire de Pharmacologie Biologique, Hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75010, Paris, France; 13: Department of Radiation Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Harvard Medical School, 25 Shattuck Street, Boston, MA, USA, 02115; 14: Boston Children's Hospital, 300, Longwood avenue, Boston, MA 02115; 15: Department of Neurology, Brigham and Women’s Hospital Boston, 75, Francis Street, Boston, MA, USA, 02115; *, co-principal investigators Running title: Highly selective activity of RG7112 in glioblastoma
منابع مشابه
Title : Preclinical efficacy of the MDM 2 inhibitor RG 7112 in MDM 2 amplified and TP 53 wild
Title: Preclinical efficacy of the MDM2 inhibitor RG7112 in MDM2 amplified and TP53 wild-type glioblastomas Authors: Maite Verreault, Charlotte Schmitt, Lauriane Goldwirt, Kristine Pelton, Samer Haidar, Camille Levasseur, Jeremy Guehennec, David Knoff, Marianne Labussiere, Yannick Marie, Azra H. Ligon, Karima Mokhtari, Khe Hoang-Xuan, Marc Sanson, Brian M Alexander, Patrick Y. Wen, Jean-Yves De...
متن کاملThe human MDM-2 oncogene is overexpressed in leukemias.
The human homologue of the mouse double minute 2 (MDM-2) gene codes for a cellular protein that forms a complex with the mutant and wild-type p53 protein and modulates its trans-activation activity. Overexpression of the MDM-2 gene in cells increases their tumorigenic potential and overcomes the growth-suppressive activity of p53. Previous reports have shown that the MDM-2 gene is amplified in ...
متن کاملAMG-232, a New Inhibitor of MDM-2,Enhance Doxorubicin Efficiency in Pre-B Acute Lymphoblastic Leukemia Cells
Background: Doxorubicin (DOX)-induced cardiotoxicity appears to be a growing concern for extensive use in acute lymphoblastic leukemia (ALL). The new combination treatment strategies, therefore might be an effective way of decreasing its side effects as well as improving efficacy. AMG232 (KRT-232) is a potential MDM-2 inhibitor, increasing available p53 through disturbing p53-MDM-2 interaction....
متن کاملImmunohistochemical localization of mdm-2, p27Kip1 and bcl-2 in Warthin's tumor of the parotid gland
BACKGROUND Warthin's tumor is a benign monomorphic adenoma with unclear origin that almost occur exclusively in the parotid gland. Etiology of Warthin's tumor as well as its malignant potential are still unclear. Therefore immunohistochemical assessment of Warthin's tumor may be useful to detect its origin or its malignant transformation potential. AIMS AND OBJECTIVES The present study aims t...
متن کاملIbrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
OBJECTIVE The aim of this study was to investigate the anti-leukemic activity of the Bruton tyrosine kinase inhibitor Ibrutinib in combination with the small molecule MDM-2 inhibitor Nutlin-3 in preclinical models. METHODS The potential efficacy of the Ibrutinib/Nutlin-3 combination was evaluated in vitro in a panel of B leukemic cell lines (EHEB, JVM-2, JVM-3, MEC-1, MEC-2) and in primary B-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2015